Mark L Brantly

Mark L Brantly, M.D.

PROFESSOR

Department: MD-PULMONARY-OTHER
Business Phone: (352) 273-8740
Business Email: brantml@medicine.ufl.edu

Publications

2019 Jama-Journal of the American Medical Association
2018 American Journal of Respiratory Cell and Molecular Biology
2017 American Journal of Respiratory Cell and Molecular Biology
2016 Proceedings of the National Academy of Sciences of the United States of America
2016 Nature Reviews Disease Primers
2013 Copd-Journal of Chronic Obstructive Pulmonary Disease
2013 Copd-Journal of Chronic Obstructive Pulmonary Disease
2009 Proceedings of the National Academy of Sciences of the United States of America
2008 Copd-Journal of Chronic Obstructive Pulmonary Disease
2004 American Journal of Physiology-Lung Cellular and Molecular Physiology

Honors & Awards

1998 · Alpha-1
1995 · Alpha-1

Board Certifications

  • Pulmonary Disease
    American Board of Internal Medicine

Clinical Profile

Specialties
  • Medicine
Subspecialties
  • Pulmonary Disease
Areas of Interest
  • Alpha-1 antitrypsin blood test
  • Alpha-1 antitrypsin deficiency
  • Chronic obstructive pulmonary disease (COPD)

Grants

Apr 2020 ACTIVE
An Adaptive Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study Assessing Efficacy and Safety of Sarilumab for Hospitalized Patients with COVID-19
REGENERON PHARMACEUTICALS · Principal Investigator
Feb 2020 ACTIVE
Alpha 1 Research Program Kamada 008 Study Task Order #1
KAMADA · Principal Investigator
Jan 2020 ACTIVE
Alpha-1 Coded Testing (ACT) Study
ALPHA ONE FOU · Principal Investigator
Oct 2019 ACTIVE
Dicerna Pharmaceuticals Consulting Agreement
DICERNA PHARMACEUTICALS · Principal Investigator
Oct 2019 ACTIVE
Dicerna A1AT-101 Study
DICERNA PHARMACEUTICALS · Principal Investigator
Jul 2019 – Oct 2019
Vertex Advisory Board Agreement for AATD Liver Disease Advisory Board July 18, 2019
VERTEX PHARMACEUTICALS · Principal Investigator
Jul 2019 ACTIVE
Alpha-1 Foundation DNA and Tissue Bank 7/1/2019 to 6/30/2020
ALPHA ONE FOU · Principal Investigator
Feb 2019 – May 2020
Alpha 1 Liver Biopsy Slides
ARROWHEAD PHARMACEUTICALS · Principal Investigator
Nov 2018 ACTIVE
Brantly MD, Mark CAG (AAT Steering Committee)
VERTEX PHARMACEUTICALS · Principal Investigator
May 2018 – Dec 2019
Kamada Consulting Master Agreement
KAMADA · Principal Investigator
Feb 2018 – Feb 2019
Vertex Consulting Agreement
VERTEX PHARMACEUTICALS · Principal Investigator
Jan 2018 ACTIVE
BAL Testing for Inhibrx rhAAT-Fc (INBRX-101)
INHIBRX · Principal Investigator
Oct 2017 ACTIVE
Adverum AAT Testing (ADVM-043-01)
ADVERUM BIOTECHNOLOGIES INC · Principal Investigator
Oct 2017 – Sep 2018
Assay Validation Service for Inhibrx Phase 1 Clinical Study of rhAAT-FC (INBRX-101)
INHIBRX · Principal Investigator
Jul 2017 – Jun 2019
Assessment of Satiety Following Oral Administration of an Erythritol Sweetened Beverage
FL CLINICAL PRACTICE ASSO · Principal Investigator
Jul 2016 – Jun 2019
Alpha-1 Foundation DNA and Tissue Bank Agreement 2016-2019
ALPHA ONE FOU · Principal Investigator
Feb 2016 ACTIVE
Quintiles Independent Contractor Agreement – Protocol 471101 (Quintiles Project Code: JXA36454)
IQVIA · Principal Investigator
Aug 2015 ACTIVE
CTSI Institutional Support
UF DIV OF SPONSORED RES MATCHING FUNDS · Project Manager
Aug 2015 – Jul 2016
Alpha-1 Antirypsin Deficiency: Understanding and
FL CLINICAL PRACTICE ASSO · Principal Investigator
Jul 2015 – Jun 2019
THE EFFECT OF OBESITY ON IMMUNE RESPONSES IN PNEUMOImmun
FL CLINICAL PRACTICE ASSO · Principal Investigator
Jul 2015 – Jan 2017
Alpha-1 Antitrypsin in African Americans and Hispanics
UNIV OF VIRGINIA · Principal Investigator
Apr 2015 ACTIVE
Clinical and Translational Science Institute (CTSI)
UF DIV OF SPONSORED RES MATCHING FUNDS · Project Manager
Oct 2014 – Oct 2017
Grifols Liquid Alpha
GRIFOLS WORLDWIDE OPERATIONS LTD · Principal Investigator
Apr 2014 – Apr 2017
Kamada-inhaled 006
KAMADA · Principal Investigator
Apr 2014 – Dec 2016
Kamada-inhaled 006 Laboratory Testing Service Agreement
KAMADA · Principal Investigator
Apr 2014 – Mar 2020
Macrophage Study
UNIV OF FLORIDA · Principal Investigator
Mar 2014 – Jul 2016
Grifols Sparta Study
*GRIFOLS WORLDWIDE OPERATIONS LTD · Principal Investigator
Jul 2013 – Jun 2016
Alpha-1 Foundation DNA and Tissue Bank 13-16
ALPHA ONE FOU · Principal Investigator
Apr 2013 ACTIVE
Liver and AAT Deficiency
UNIV OF FLORIDA · Principal Investigator
Jan 2013 – Dec 2016
Kamada 007-EU Laboratory Testing Service Agreement for A1RP-INST-AAT-007
KAMADA · Principal Investigator
Jul 2012 – Jun 2016
State of Florida Testing Service Grant Agreement
ALPHA ONE FOU · Principal Investigator
Jul 2012 – Jun 2016
ACT Program Testing Service Grant Agreement
ALPHA ONE FOU · Principal Investigator
Jun 2010 ACTIVE
Alpha-1 Research Program Multiple Sponsors Project
MULTIPLE SPONSORS · Principal Investigator
May 2010 – Dec 2016
Reference Laboratory for "A Multiple-Site, Phase 2, Safe
APPLIED GENETICS TECH CORP · Principal Investigator
Jul 2008 – Jun 2018
Pulmonary Med Cystic Fibrosis
UF FOU · Principal Investigator
Apr 2004 – Mar 2020
Lung Transplant Research Fund
UF FOU · Principal Investigator
Oct 2002 ACTIVE
Alpha One Professorship
UF FOU · Principal Investigator
Jun 2001 ACTIVE
01040902
GRIFOLS WORLDWIDE OPERATIONS LTD · Principal Investigator

Patents

Issued May 2013
Compounds and Methods for Treatment of Alpha-1 Antitrypsin Deficiency
#8,436,013

Education

Fellowship – Pulmonary Disease
1986 · National Institutes of Health
Residency – Internal Medicine
1983 · Ghent Family Practice
Residency – Family Medicine
1980 · Ghent Family Practice
Medical Degree
1979 · University of Florida
Bachelor of Science
1976 · Florida State University

Contact Details

Phones:
Business:
(352) 273-8740
Emails: